Martin Shkreli's legacy: Putting a 'fine point' on the drug pricing debate
March 09, 2018 at 07:57 AM EST
Martin Shkreli's actions involving pharmaceutical pricing have had a long-lasting impact.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|